Menu

Current research projects

TELESCOPE – genetic screening study for those with geographical atrophy due to Dry AMD, recruiting till Nov 2021

There are 2 sites helping to recruit participants locally.

Vision and Hearing Support, Gateshead – contact Stephanie.cairns1@nhs.net

Simon Berry Opticians – Simon@simonberry.co.uk 

If you have potentially suitable patients who may like to participate please email either of the Optometrists above for further details. There will be referral fee for any patients recruited specifically for TELESCOPE.

    • The study consists of 1 visit, where patients who provide their informed consent will be asked to provide a saliva sample that is shipped to a central laboratory for genotyping.
    • If the patient meets the pre-specified genotype criteria, they may be able to enroll in an ongoing interventional gene therapy clinical trial.
    • Inclusion Criteria 

      Subjects entered into the study must meet the following criteria:

      Aged ≥55 years

      Able and willing to give consent to study participation

      Presence of unilateral or bilateral GA due to AMD

      Exclusion Criteria

      Subjects will not be eligible for the study if they meet any of the following criteria:

      History or evidence of choroidal neovascularization (for example, wet AMD) in the either eye.

      Presence of severe non-proliferative diabetic retinopathy or worse in either eye

      Previous intravitreal injection in either eye for the treatment of nAMD.

      Participation in another research study involving an investigational product received within 5 half-lives prior to the study visit or within 4 weeks until the expected pharmacodynamic effect has returned to baseline, whichever is longer

      Received gene/cell therapy at any time previously.

      AgeRelated Macular Degeneration Infographic_V2_18JAN2021

      Patient Flyer_V2_11MAR2021

      Patient Participant Journey_V2_11MAR2021

      Downloadable  Poster_V2_11MAR2021

Follow the committee on Facebook and Twitter for news on meetings, events and CET